Stay updated on Crenezumab in PSEN1 E280A Mutation Clinical Trial
Sign up to get notified when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.

Latest updates to the Crenezumab in PSEN1 E280A Mutation Clinical Trial page
- Check7 days agoChange DetectedThe updates appear limited to formatting and layout adjustments on the Study Details page, with no changes to core study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated the page to v3.2.0 and added a prominent government funding/operating-status notice for the NIH Clinical Center; removed the previous v3.1.0 tag.SummaryDifference2%

- Check43 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations related to Alzheimer's care, as well as the introduction of topics concerning drug safety and counterfeit drugs. Notably, the previous references to certain locations and resources have been removed.SummaryDifference0.8%

Stay in the know with updates to Crenezumab in PSEN1 E280A Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.